caf01
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT00922363)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- caf01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02787109 | Phase 1 | Jul 1, 2016 | Statens Serum Institut, University of London |
| NCT00922363 | Phase 1 | Oct 1, 2009 | Statens Serum Institut |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Statens Serum Institut | Academic/Hospital | 2 | 2 | 1 | 2009 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1